{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists", "item": "https://www.patentleaderboard.com/patent/6103737"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists

Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists

US Patent 6103737 · Granted Aug 15, 2000

Estimated economic value: $1,295,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Percutaneous osseointegrated implant assembly for use in supporting an exo-prost2024
Percutaneous osseointegrated implant assembly for use in supporting an exo-prost2022
Plasma speaker2020
Dihydropyridone P1 as factor XIa inhibitors2018
Macrocycles as factor XIa inhibitors2018
Percutaneous osseointegrated prosthetic implant system2017
Macrocycles as factor XIa inhibitors2017
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to bloc2016
Percutaneous osseointegrated implant assembly for use in supporting an exo-prost2016
Dihydropyridone p1 as factor XIa inhibitors2016
Dihydropyridone P1 as factor XIa inhibitors2016
Macrocycles as factor XIa inhibitors2015